### Anti-Obesity Medications and Food Waste: An Intricate Connection
A recent study has uncovered an unforeseen effect of anti-obesity medications: an increase in food waste among some Americans. As the use of drugs like GLP-1 agonists becomes more prevalent to address obesity and type 2 diabetes, they are influencing not just dietary practices but also food consumption, disposal, and value perceptions within households. These insights trigger important questions regarding consumer behavior, economic consequences, and environmental sustainability over time.
—
### The Surge of Anti-Obesity Medications in the U.S.
Medications aimed at combating obesity, including **semaglutide** (known as Ozempic, Rybelsus, and Wegovy) and **terzepatide** (branded as Mounjaro), have seen a significant uptick in usage in American homes. As of Spring 2023, around **6% of U.S. adults** reported taking these GLP-1 agonists, which function by imitating a hormone in the small intestine to manage blood sugar levels, extend stomach emptying duration, and send fullness signals to the brain.
These drugs have demonstrated impressive efficacy: those participating in the study indicated an average weight loss of **20%** after a year or more of treatment. Nevertheless, they also reported meaningful shifts in their eating habits—shifts that might unintentionally contribute to increased food waste.
—
### Increased Food Waste: Insights from the Study
The research surveyed **505 U.S. adults** currently using anti-obesity medications to assess their food waste habits prior to and following their initiation of the drugs. Among the participants, nearly **70%** were on semaglutide, while close to **25%** used terzepatide. Respondents were prompted to express their agreement with the statement: *“Since starting this medication, I have noticed I waste more of the food I buy.”*
The results uncovered:
– **Higher food waste**: Those who had been on the medications for **90 days or less** were **30% more likely** to report increased food waste in comparison to those on the medications for a year or longer.
– **Nausea and altered preferences**: Many participants linked their food waste to the **nausea** that often accompanies GLP-1 agonists. Others noted changes in their food preferences or routines—for example, discarding foods that no longer matched their healthier, reduced-calorie diets.
– **Dietary improvements**: Numerous individuals on these medications reported incorporating more **produce, protein, fish, and healthy fats** into their meals, while decreasing their intake of **pasta, fried items, sweets, alcohol, dairy, and other carbohydrates**. The heightened emphasis on vegetables—**the food group most often wasted in the U.S.**—was associated with a lower tendency to report additional waste, suggesting that individuals might be consuming their newly veggie-rich meals rather than throwing them away.
—
### A Comprehensive Examination of Food Waste in the U.S.
Food waste presents a major issue in the United States. Roughly **one-third of all food**—worth billions—is discarded each year, with consumers accounting for approximately **50%** of this waste. According to estimates by the National Academies, the average individual disposes of **1 pound of food daily**.
The emergence of anti-obesity medications introduces a fresh layer to the food waste dilemma. While these medications can encourage healthier eating patterns centered on higher-quality, nutrient-rich foods, nausea and evolving preferences may lead to the disposal of these healthier options.
—
### Economic Factors: Food Versus Medication Costs
One pressing inquiry posed by principal investigator Roe, a professor at Ohio State University, is whether individuals using GLP-1 agonists potentially spend **less on food** due to a decrease in consumption, which might counterbalance the substantial costs of these medications. However, this remains an unanswered question. The economic ripple effects could extend beyond individual consumers, influencing local and global economies associated with food systems.
Moreover, as **prescription rates for GLP-1 agonists continue to escalate**, researchers are wary of broader economic and environmental ramifications. A decline in food consumption at the population level may decrease energy expenses, conserve land and water, and lower greenhouse gas emissions by minimizing waste in landfills. However, with these medications still relatively new to the market, sufficient long-term data is lacking to forecast the extent of these potential effects.
—
### Environmental and Public Health Effects of Consumption Changes
There is increasing evidence that shifts in dietary patterns across the population can impact global food systems and sustainability:
1. **Conserved Resource Use**: Overall reductions in food consumption could protect agricultural land, lessen water usage, and lower waste management expenses.
2. **Healthier, More Sustainable Dietary Choices**: Many users of these drugs are moving away from calorie-heavy and environmentally burdensome foods